These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 19822523)

  • 21. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
    Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
    Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells.
    Zhang J; Thorikay M; van der Zon G; van Dinther M; Ten Dijke P
    J Vis Exp; 2020 Oct; (164):. PubMed ID: 33191940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.
    Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC
    Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCT6A suppresses SMAD2 and promotes prometastatic TGF-β signaling.
    Ying Z; Tian H; Li Y; Lian R; Li W; Wu S; Zhang HZ; Wu J; Liu L; Song J; Guan H; Cai J; Zhu X; Li J; Li M
    J Clin Invest; 2017 May; 127(5):1725-1740. PubMed ID: 28375158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The type III TGF-beta receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-beta signaling.
    Lee JD; Hempel N; Lee NY; Blobe GC
    Carcinogenesis; 2010 Feb; 31(2):175-83. PubMed ID: 19955393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small C-terminal domain phosphatases dephosphorylate the regulatory linker regions of Smad2 and Smad3 to enhance transforming growth factor-beta signaling.
    Wrighton KH; Willis D; Long J; Liu F; Lin X; Feng XH
    J Biol Chem; 2006 Dec; 281(50):38365-75. PubMed ID: 17035229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.
    Piek E; Ju WJ; Heyer J; Escalante-Alcalde D; Stewart CL; Weinstein M; Deng C; Kucherlapati R; Bottinger EP; Roberts AB
    J Biol Chem; 2001 Jun; 276(23):19945-53. PubMed ID: 11262418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism.
    Lee YH; Albig AR; Regner M; Schiemann BJ; Schiemann WP
    Carcinogenesis; 2008 Dec; 29(12):2243-51. PubMed ID: 18713838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.
    Landis MD; Seachrist DD; Montañez-Wiscovich ME; Danielpour D; Keri RA
    Oncogene; 2005 Aug; 24(33):5173-90. PubMed ID: 15897883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
    Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
    Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activated Abl kinase inhibits oncogenic transforming growth factor-beta signaling and tumorigenesis in mammary tumors.
    Allington TM; Galliher-Beckley AJ; Schiemann WP
    FASEB J; 2009 Dec; 23(12):4231-43. PubMed ID: 19690215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
    Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB
    Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
    Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
    Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-β/Smad2/3 signaling directly regulates several miRNAs in mouse ES cells and early embryos.
    Redshaw N; Camps C; Sharma V; Motallebipour M; Guzman-Ayala M; Oikonomopoulos S; Thymiakou E; Ragoussis J; Episkopou V
    PLoS One; 2013; 8(1):e55186. PubMed ID: 23390484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p38 MAPK is an early determinant of promiscuous Smad2/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice.
    Carta L; Smaldone S; Zilberberg L; Loch D; Dietz HC; Rifkin DB; Ramirez F
    J Biol Chem; 2009 Feb; 284(9):5630-6. PubMed ID: 19109253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TrkC binds to the type II TGF-beta receptor to suppress TGF-beta signaling.
    Jin W; Yun C; Kwak MK; Kim TA; Kim SJ
    Oncogene; 2007 Dec; 26(55):7684-91. PubMed ID: 17546043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
    Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
    Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1.
    Tornillo G; Bisaro B; Camacho-Leal Mdel P; Galiè M; Provero P; Di Stefano P; Turco E; Defilippi P; Cabodi S
    Eur J Cell Biol; 2011; 90(2-3):237-48. PubMed ID: 20961652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
    Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
    Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The phosphorylation of the Smad2/3 linker region by nemo-like kinase regulates TGF-β signaling.
    Liang J; Zhou Y; Zhang N; Wang D; Cheng X; Li K; Huang R; Lu Y; Wang H; Han D; Wu W; Han M; Miao S; Wang L; Zhao H; Song W
    J Biol Chem; 2021; 296():100512. PubMed ID: 33676893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.